美国不同种族和族裔在接受非整倍体植入前遗传学检测中的结局差异
该回顾性队列研究基于2014-2020年SART CORS数据库,纳入438583个自体ART周期,比较不同种族和族裔使用PGT-A后的活产、宫内妊娠和流产率。结果显示,使用PGT-A的黑人和西班牙裔女性流产率仍高于白人女性,且宫内妊娠率和活产率更低;但PGT-A使用与所有种族和族裔的较低流产率相关。
要点
- 使用PGT-A的黑人女性宫内妊娠和活产几率仍低于白人女性。
- PGT-A使用与所有种族和族裔的较低流产率相关。
- 种族和族裔是PGT-A周期结局的独立预测因素。
核心结论
- 尽管使用PGT-A,黑人和西班牙裔女性的流产率仍高于白人女性,宫内妊娠率和活产率更低。
- PGT-A使用与每个种族和族裔的较低流产率相关。
研究设计与样本
- 回顾性队列分析,使用2014-2020年SART CORS数据。
- 纳入438583个ART周期,其中150604个PGT-A周期和287979个非PGT-A周期,均为首次自体单囊胚移植周期。
主要发现
- 白人女性使用PGT-A的活产率下降(37.4% vs 39.7%,P<.001,校正P>.05)。
- 亚洲女性使用PGT-A的宫内妊娠率(34.7% vs 30.4%,P<.001)和活产率(31.4% vs 27.3%,P<.001)均升高。
- 所有种族和族裔使用PGT-A均与较低流产率相关。
- 使用PGT-A的黑人女性宫内妊娠和活产几率分别比白人女性低13%(aOR 0.87,95%CI 0.86-0.91,P<.001)和17%(aOR 0.83,95%CI 0.81-0.85,P<.001)。
- 使用PGT-A的黑人女性流产率与未使用PGT-A的白人女性相似(16.7% vs 16.5%)。
临床怎么用
- 咨询时应告知黑人和西班牙裔女性,即使使用PGT-A,其流产率仍可能高于白人女性。
- PGT-A可降低所有种族和族裔的流产率,但需个体化评估预期结局。
局限性
- 回顾性研究设计可能存在未测量混杂因素。
- 仅纳入首次自体单囊胚移植周期,结论外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To determine live birth, intrauterine pregnancy, and miscarriage rates in cycles using preimplantation genetic testing for aneuploidy (PGT-A) as a function of race and ethnicity. METHODS: This retrospective cohort analysis used data collected from the Society of Assisted Reproductive Technology Clinical Outcomes Reporting System (SART CORS). Women who underwent their first autologous cycle that resulted in a primary transfer from 2014 to 2020 with the intent of assisted reproductive technology (ART) with and without PGT-A were included in this study. We compared live birth, intrauterine pregnancy, and miscarriage rates by race and ethnicity (American Indian/Alaska Native, Asian, Black, Hispanic, Native Hawaiian/Other Pacific Islander, and White). Statistical analyses of live birth, intrauterine pregnancy, and miscarriage rates with t tests and multiple logistic regression were used to determine adjusted odds ratios (aORs). RESULTS: A total of 438,583 ART cycles were included with 150,604 PGT-A and 287,979 non-PGT-A primary autologous cycles with a single blastocyst transfer. There was a decrease in live-birth rate in White women using PGT-A (37.4% vs 39.7%, P <.001, P adjusted>.05). Live-birth rates were similar in PGT-A cycles of Black and Hispanic women compared with non-PGT-A cycles. Asian women who used PGT-A had higher intrauterine pregnancy rate (34.7% vs 30.4%, P <.001) and live-birth rate (31.4% vs 27.3%, P <.001) compared with Asian women who did not. The intrauterine pregnancy rate for White women regardless of PGT-A use was the same (40.8% vs 40.8%, P >.05), whereas Black and Hispanic women had a slightly increased rate of intrauterine pregnancy rate with PGT-A. For all races and ethnicities, PGT-A use was associated with a lower miscarriage rate. In Black and Hispanic women using PGT-A, there were higher rates of miscarriage and lower rates of intrauterine pregnancy and live-birth rates compared with White women using PGT-A. After adjustment for demographic and clinical confounders, race and ethnicity remained independent predictors for live birth, intrauterine pregnancy, and miscarriage in women using PGT-A. Race and ethnicity, PGT-A use, age 35 years or older, high body mass index (BMI), and low anti-müllerian hormone levels were independent predictors of miscarriage. Despite PGT-A use, Black women were 13% (aOR 0.87, 95% CI, 0.86-0.91, P <.001) and 17% (aOR 0.83, 95% CI, 0.81-0.85, P <.001) less likely to have an intrauterine pregnancy and live birth, respectively, compared with White women who used PGT-A. Of note, the miscarriage rate in Black women using PGT-A was similar to that in White women not using PGT-A (16.7% and 16.5%). CONCLUSION: Despite PGT-A use, Black and Hispanic women continue to have higher miscarriage rates and lower intrauterine pregnancy and live-birth rates compared with White women using PGT-A. However, the use of PGT-A is associated with lower miscarriage rate for women of each race and ethnic group compared with nonusers of PGT-A.
引用
- Mason-Otey A, Seifer DB. U.S. Racial and Ethnic Disparities in Outcomes Using Preimplantation Genetic Testing for Aneuploidies: An Analysis of 2014-2020 SART CORS Database. Obstet Gynecol. 2026. PMID: 41785458. doi:10.1097/AOG.0000000000006234
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。